Filing Details
- Accession Number:
- 0001225208-23-005616
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-09 19:48:36
- Reporting Period:
- 2023-05-07
- Accepted Time:
- 2023-05-09 19:48:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1438538 | M. Catherine Szyman | One Edwards Way Irvine CA 92614 | Cvp, Critical Care | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-05-07 | 4,708 | $0.00 | 32,061 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-07 | 2,154 | $88.74 | 29,907 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-05-08 | 1,376 | $88.74 | 28,531 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2023-05-09 | 75,600 | $35.20 | 104,131 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-09 | 75,600 | $88.94 | 28,531 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Rights | Disposition | 2023-05-07 | 4,708 | $0.00 | 4,708 | $0.00 |
| Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2023-05-09 | 75,600 | $0.00 | 75,600 | $35.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,292 | 2023-05-07 | 2027-05-06 | No | 4 | M | Direct |
| 0 | 2017-05-12 | 2023-05-11 | No | 4 | M | Direct |
Footnotes
- On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4.
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2023.
- This transaction was executed in multiple trades at prices ranging from $88.35 to $89.14 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
